Literature DB >> 18551311

Genetics of a combined lung small cell carcinoma and large cell neuroendocrine carcinoma with adenocarcinoma.

Giovanni Fellegara1, Tiziana D'Adda, Francesco P Pilato, Elisabetta Froio, Luca Ampollini, Michele Rusca, Guido Rindi.   

Abstract

Combined nonneuroendocrine-neuroendocrine lung tumors are relatively infrequent and little is known as for their genetic basis. Here, we report the case of a 69-year-old male with a solitary neoplasm in the upper lobe of the right lung. At histological examination, the tumor showed two components. The main part was an adenocarcinoma of the acinar type. The second part showed morphological and immunohistochemical phenotype of a neuroendocrine carcinoma composed of a small cell lung carcinoma and a large cell neuroendocrine carcinoma. The aim of our study was to investigate the genetic relationship between neuroendocrine and nonneuroendocrine tumor components. To this purpose, we performed a loss of heterozygosity (LOH) analysis with 40 chromosomal microsatellite markers. Microallelotyping revealed a common genetic profile in the different tumor areas. In 9 of 30 informative regions analyzed, LOH involved the same allele in all components, regardless of their histological type and grade. These findings support the true combined nature of this exocrine-neuroendocrine carcinoma of the lung and suggest a common monoclonal origin from a pluripotent epithelial (alveolar or bronchial) precursor cell for the two different tumor components.

Entities:  

Mesh:

Year:  2008        PMID: 18551311     DOI: 10.1007/s00428-008-0620-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  23 in total

Review 1.  Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.

Authors:  Sanja Dacic
Journal:  Expert Rev Mol Diagn       Date:  2007-01       Impact factor: 5.225

2.  Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases.

Authors:  V L Roggli; R T Vollmer; S D Greenberg; M H McGavran; H J Spjut; R Yesner
Journal:  Hum Pathol       Date:  1985-06       Impact factor: 3.466

3.  Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung.

Authors:  N Sturm; S Lantuéjoul; M H Laverrière; M Papotti; P Y Brichon; C Brambilla; E Brambilla
Journal:  Hum Pathol       Date:  2001-09       Impact factor: 3.466

4.  Cellular heterogeneity in lung cancer.

Authors:  M S Dunnill; K C Gatter
Journal:  Histopathology       Date:  1986-05       Impact factor: 5.087

5.  Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids.

Authors:  Nathalie Sturm; Giulio Rossi; Sylvie Lantuejoul; Mauro Papotti; Sophie Frachon; Christine Claraz; Pierre-Yves Brichon; Christian Brambilla; Elisabeth Brambilla
Journal:  Hum Pathol       Date:  2002-02       Impact factor: 3.466

6.  Clonality of combined tumors.

Authors:  Jiaoti Huang; Carmen Behrens; Ignacio I Wistuba; Adi F Gazdar; Jaishree Jagirdar
Journal:  Arch Pathol Lab Med       Date:  2002-04       Impact factor: 5.534

Review 7.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

8.  Combined carcinoid tumor of the lung: a combination of carcinoid and adenocarcinoma.

Authors:  F Sen; A C Borczuk
Journal:  Lung Cancer       Date:  1998-07       Impact factor: 5.705

9.  Microallelotyping defines the monoclonal or the polyclonal origin of mixed and collision endocrine-exocrine tumors of the gut.

Authors:  Daniela Furlan; Roberta Cerutti; Anna Genasetti; Giuseppe Pelosi; Silvia Uccella; Stefano La Rosa; Carlo Capella
Journal:  Lab Invest       Date:  2003-07       Impact factor: 5.662

10.  Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization.

Authors:  R Ullmann; A Schwendel; H Klemen; G Wolf; I Petersen; H H Popper
Journal:  Hum Pathol       Date:  1998-10       Impact factor: 3.466

View more
  3 in total

Review 1.  [Gastrointestinal mixed adenoneuroendocrine carcinomas. An attempt at classification of mixed cancers].

Authors:  S Reu; J Neumann; T Kirchner
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

Review 2.  Are neuroendocrine negative small cell lung cancer and large cell neuroendocrine carcinoma with WT RB1 two faces of the same entity?

Authors:  Dmitriy Sonkin; Anish Thomas; Beverly A Teicher
Journal:  Lung Cancer Manag       Date:  2019-08-21

3.  Applying unmixing to gene expression data for tumor phylogeny inference.

Authors:  Russell Schwartz; Stanley E Shackney
Journal:  BMC Bioinformatics       Date:  2010-01-20       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.